筛窦与上颌窦浑浊比值对鼻息肉病术后嗅觉及结局的预测作用
本研究前瞻性纳入165例北美CRSwNP患者,分析术前E/M比值与ESS术后嗅觉、SNOT-22及息肉复发的关系。结果显示E/M比值升高与术前较差的BSIT评分相关,且与术后BSIT达到临床重要改善的可能性增加相关,但与SNOT-22改善或息肉复发无关。
要点
- 术前E/M比值升高与CRSwNP患者基线嗅觉较差相关。
- E/M比值升高预示ESS术后嗅觉获得临床重要改善的可能性更大。
- E/M比值不能预测SNOT-22改善或息肉复发。
核心结论
- 在北美CRSwNP人群中,E/M比值升高与基线嗅觉较差及术后嗅觉获得临床有意义改善的可能性增加相关。
- E/M比值升高不能预测SNOT-22术后变化或息肉复发。
研究设计与样本
- 前瞻性、观察性、多机构研究,纳入165例接受ESS的北美成人CRSwNP患者。
- 根据Lund-Mackay评分计算E/M比值并进行分层。
主要发现
- 所有患者术后SNOT-22总分及各域评分和BSIT结果均较术前显著改善(p ≤ 0.019)。
- 术前E/M比值升高与较差的BSIT评分相关(r = -0.343,p < 0.001)。
- 术后E/M比值升高与BSIT改善相关(r = 0.284,p = 0.002),但与SNOT-22改善或息肉复发无相关性。
- E/M比值升高与BSIT评分达到最小临床重要差异的可能性增加相关(χ2 = 9.96,p = 0.041)。
关键数值与推荐
- E/M比值基于Lund-Mackay评分计算。
- 嗅觉评估采用BSIT,生活质量评估采用SNOT-22,内镜评估采用Lund-Kennedy评分。
临床怎么用
- 术前E/M比值可作为北美CRSwNP患者ESS术后嗅觉改善的预测参考。
- E/M比值不宜用于预测SNOT-22改善或息肉复发。
局限性
- 研究仅纳入北美人群,结论外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory profiles for patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) vary between North American and Asian populations. An elevated ethmoid-to-maxillary (E/M) opacification ratio on preoperative imaging is associated with certain postoperative outcomes in Asian populations and populations that are non-type 2 dominant. In this study we explore this factor in North American/type 2-based populations. METHODS: Adult patients (n = 165) from a North American population with CRSwNP who underwent endoscopic sinus surgery (ESS) were prospectively enrolled into an observational, multi-institutional study. The 22-item Sino-Nasal Outcome Test (SNOT-22), Brief Smell Identification Test (BSIT), and Lund-Kennedy (LK) endoscopic scores were obtained pre- and postoperatively. Patients were stratified according to increasing E/M ratios based on Lund-Mackay (LM) scores. RESULTS: On average, significant within-subject postoperative improvement was found in all patients for SNOT-22 total and domain scores, and also BSIT results (p ≤ 0.019). Preoperatively, elevated E/M ratio correlated with worse BSIT scores (r = -0.343, p < 0.001). Postoperatively, elevated E/M ratio correlated with BSIT improvement (r = 0.284, p = 0.002), but did not correlate with SNOT-22 improvement or polyp recurrence. An elevated E/M ratio was associated with greater likelihood of reporting a minimal clinically important difference in BSIT scores (χ2 = 9.96, p = 0.041). CONCLUSION: Elevated E/M ratios were found to associated with worse baseline olfaction and an increased likelihood of achieving a clinically meaningful postoperative improvement in olfaction in this North American population with CRSwNP. Elevated E/M ratios did not predict postoperative changes in SNOT-22 measures or polyp recurrence. This suggests that prognostic factors may vary according to geography and generalized inflammatory profiles (type 2 vs non-type 2) in patients with CRS.
引用
- Beswick DM, Smith TL, Mace JC, et al. Ethmoid-to-maxillary opacification ratio: a predictor of postoperative olfaction and outcomes in nasal polyposis? Int Forum Allergy Rhinol. 2020. PMID: 32558260. doi:10.1002/alr.22625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。